WOOJUNG BIO Statistics

Total Valuation

WOOJUNG BIO has a market cap or net worth of KRW 34.94 billion. The enterprise value is 81.84 billion.

Market Cap	34.94B
Enterprise Value	81.84B

Important Dates

Earnings Date	n/a
Ex-Dividend Date	n/a

Share Statistics

WOOJUNG BIO has 15.88 million shares outstanding. The number of shares has increased by 41.73% in one year.

Shares Outstanding	15.88M
Shares Change (YoY)	+41.73%
Shares Change (QoQ)	+38.46%
Owned by Insiders (%)	35.34%
Owned by Institutions (%)	3.87%
Float	10.27M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	0.65
PB Ratio	1.26
P/FCF Ratio	34.74
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 22.63, with an EV/FCF ratio of 81.39.

EV / Earnings	69.31
EV / Sales	1.83
EV / EBITDA	22.63
EV / EBIT	n/a
EV / FCF	81.39

Financial Position

The company has a current ratio of 0.41, with a Debt / Equity ratio of 1.96.

Current Ratio	0.41
Quick Ratio	0.20
Debt / Equity	1.96
Debt / EBITDA	13.78
Debt / FCF	49.56
Interest Coverage	-0.24

Financial Efficiency

Return on equity (ROE) is 4.08% and return on invested capital (ROIC) is -0.64%.

Return on Equity (ROE)	4.08%
Return on Assets (ROA)	-0.54%
Return on Capital (ROIC)	-0.64%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.48
Inventory Turnover	7.65

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -6.91% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-6.91%
50-Day Moving Average	2,201.16
200-Day Moving Average	1,837.37
Relative Strength Index (RSI)	46.69
Average Volume (20 Days)	3,646,709

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WOOJUNG BIO had revenue of KRW 44.75 billion and earned 1.18 billion in profits.

Revenue	44.75B
Gross Profit	9.49B
Operating Income	-806.14M
Pretax Income	1.18B
Net Income	1.18B
EBITDA	3.62B
EBIT	-806.14M
Earnings Per Share (EPS)	-127.02

Full Income Statement

Balance Sheet

The company has 2.93 billion in cash and 49.83 billion in debt, giving a net cash position of -46.90 billion or -2,953.52 per share.

Cash & Cash Equivalents	2.93B
Total Debt	49.83B
Net Cash	-46.90B
Net Cash Per Share	-2,953.52
Equity (Book Value)	25.47B
Book Value Per Share	1,752.33
Working Capital	-21.04B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 1.53 billion and capital expenditures -519.53 million, giving a free cash flow of 1.01 billion.

Operating Cash Flow	1.53B
Capital Expenditures	-519.53M
Free Cash Flow	1.01B
FCF Per Share	63.32

Full Cash Flow Statement

Margins

Gross margin is 21.20%, with operating and profit margins of -1.80% and 2.64%.

Gross Margin	21.20%
Operating Margin	-1.80%
Pretax Margin	2.64%
Profit Margin	2.64%
EBITDA Margin	8.08%
EBIT Margin	-1.80%
FCF Margin	2.25%

Dividends & Yields

WOOJUNG BIO does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-41.73%
Shareholder Yield	-41.73%
Earnings Yield	-5.77%
FCF Yield	2.88%

Stock Splits

The last stock split was on July 30, 2019. It was a forward split with a ratio of 2.

Last Split Date	Jul 30, 2019
Split Type	Forward
Split Ratio	2

Scores

WOOJUNG BIO has an Altman Z-Score of 0.06. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.06
Piotroski F-Score	n/a